Who owns PASITHEA THERAPEUTICS CORP?
- Ticker: KTTA
- CUSIP Number: 70261f202
Tip: Access positions for across all investors
Analyze quarterly positions in Pasithea Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pasithea Therapeutics Corp stock
Who bought or sold PASITHEA THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cable Car Capital | 3.0M | $1.5M | 149% | Jun 2026 |
|
| Stonepine Capital Management | 2.2M | $1.1M | 165% | Jun 2026 |
|
| Henderson Group | 2.1M | $1.6M | 100% | Mar 2026 |
|
| Adage Capital Partners GP | 2.1M | $1.1M | 0% | Jun 2026 |
|
| Jupiter Topco | 2.1M | $1.1M | 100% | Jun 2026 |
|
| Opaleye Management | 2.1M | $1.1M | 100% | Jun 2026 |
|
| Ameriprise Financial | 1.9M | $961k | 38% | Jun 2026 |
|
| Squadron Capital Management | 1.0M | $515k | -52% | Jun 2026 |
|
| AdvisorShares Investments | 938k | $483k | 178% | Jun 2026 |
|
| Vivo Capital | 466k | $240k | -78% | Jun 2026 |
|
| Persistent Asset Partners | 291k | $150k | 0% | Jun 2026 |
|
| UBS Group | 188k | $97k | 619% | Jun 2026 |
|
| XTX Topco | 128k | $66k | 278% | Jun 2026 |
|
| Vanguard Capital Management | 126k | $65k | 135% | Jun 2026 |
|
| Geode Capital Management | 84k | $43k | -19% | Jun 2026 |
|
| Renaissance Technologies | 66k | $34k | -30% | Jun 2026 |
|
| Two Sigma Investments | 64k | $33k | 205% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 44k | $23k | 0% | Jun 2026 |
|
| Northern Trust | 31k | $16k | 62% | Jun 2026 |
|
| Jump Financial | 29k | $15k | 100% | Jun 2026 |
|
| Tower Research Capital | 8.8k | $4.6k | 377% | Jun 2026 |
|
| Hurley Capital | 7.0k | $3.6k | 90% | Jun 2026 |
|
| SBI Securities | 1.1k | $542.000700 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 275.00 | $0 | 100% | Jun 2026 |
|
| Barclays | 269.00 | $138.992300 | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 150.00 | $79.005000 | 100% | Jun 2026 |
|